ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,070Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 103

$644K Total Retail Price of All Prescriptions

Rank: 21 out of 103

456 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 456 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 456 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 9,629 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LISINOPRIL 502 449 1 5
OMEPRAZOLE 491 473 2 3
SIMVASTATIN 403 375 3 2
FUROSEMIDE 368 336 4 4
LEVOTHYROXINE SODIUM 328 286 5 1
HYDROCODONE-ACETAMINOPHEN 292 241 S3 6 11
TRAMADOL HCL 289 248 7 17
AMLODIPINE BESYLATE 286 267 8 6
HYDROCHLOROTHIAZIDE 262 244 9 16
WARFARIN SODIUM 256 224 10 7
METOPROLOL TARTRATE 228 212 11 9
ALENDRONATE SODIUM 203 203 12 19
POTASSIUM CHLORIDE 179 161 13 10
TAMSULOSIN HCL 176 154 14 23
CITALOPRAM HBR 173 154 15 15
METOPROLOL SUCCINATE 170 169 16 8
METFORMIN HCL 165 132 17 13
ALBUTEROL SULFATE 164 164 18 68
ATENOLOL 146 140 19 14
FLUTICASONE PROPIONATE 131 98 20 35
GABAPENTIN 122 98 21 22
CRESTOR 119 114 22 27
GLIPIZIDE 109 92 23 65
DONEPEZIL HCL 100 100 24 28
RANITIDINE HCL 99 91 25 53
ATORVASTATIN CALCIUM 97 91 26 18
CLOPIDOGREL 97 97 26 32
LOSARTAN POTASSIUM 96 83 28 12
MELOXICAM 94 93 29 49
DIGOXIN 90 80 30 25
ADVAIR DISKUS 88 76 31 42
PREDNISONE 85 65 32 24
DIOVAN 80 68 33 40
FLUOXETINE HCL 75 60 34 92
POLYETHYLENE GLYCOL 3350 74 70 35 31
LANSOPRAZOLE 71 44 36 134
BUDESONIDE 71 71 36 163
PLAVIX 70 70 38 46
CARVEDILOL 70 59 38 20
AVODART 63 63 40 115
SPIRIVA 63 60 40 64
IPRATROPIUM BROMIDE 63 60 40 128
PANTOPRAZOLE SODIUM 60 52 43 95
ROPINIROLE HCL 60 60 43 77
NAPROXEN 60 40 43 148
ISOSORBIDE MONONITRATE ER 60 60 43 37
PRAVASTATIN SODIUM 58 54 47 33
FENTANYL 57 42 S2 48 34
MIRTAZAPINE 56 44 49 36
ZETIA 56 38 49 66
NAMENDA 55 55 51 41
BENICAR 50 49 52 240
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.